Search Tag: endoluminal cancer

IMAGING Management

2022 16 Jun

David Webster  has been appointed the new Chief Executive Officer (CEO) of Body Vision Medical, a medical device company whose mission is to make artificial intelligence (AI)-driven imaging the standard of care for diagnosis and treatment of endoluminal cancer. The company's first offering is an advanced imaging system that maximizes diagnosis of...Read more